Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-06-Speech-3-354-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-04-06"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"es"^^xsd:language2
lpv:document identification number	"en.20110406.29.3-354-000"2
lpv:hasSubsequent	lp_eu:2011-04-06-Speech-3-355-0002
lpv:speaker	lp:Izaskun Bilbao Barandica2
lpv:spokenAs	unknown; Partido Nacionalista Vasco (2009-07-14--2014-06-30)3 member_of_the_bureau; ALDE (2009-07-20--2014-06-30)3 substitute; FEMM (2009-07-16--2012-01-18)3 member; TRAN (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the Mercosur countries (2009-09-16--2014-06-30)3 vice-chair; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3 substitute; PECH (2009-07-16--2012-01-18)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"I voted against this initiative because, in accordance with the procedure laid down in Regulation (EC) No 1924/2006, the health claim that docosahexaenoic acid (DHA) intake contributes to the normal visual development of infants between six and 12 months of age could not be concluded from the experts’ opinion communicated to the Commission. What is more, a report published in June 2010 in the British Medical Journal found that 10 years after being fed with DHA fortified formula, children were heavier and had higher blood pressure. There is no clear scientific consensus on the effects of formula fortified with DHA on infants, which runs contrary to Articles 5 and 6 of the regulation in question. As the claim is incompatible with the purpose and content of the draft regulation, I therefore voted against its adoption."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph